GlassScriptPhysician profile
Gina Han
NPI 1346849742
$1,651.98
in general payments reported to CMS, 2019-2025
15 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $391 · 2024: $249 · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,651.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $296.63 | 2023-2025 | |
| Galderma Laboratories, L.P. | $248.55 | 2024 | Dysport |
| Pfizer INC. | $211.32 | 2025 | |
| Journey Medical Corporation | $163.39 | 2023-2025 | |
| Revance Therapeutics, INC. | $161.05 | 2025 | Daxxify |
| Incyte Corporation | $154.56 | 2025 | Opzelura |
| Merz North America, INC. | $83.46 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $63.29 | 2023 | Sotyktu |
| Lilly USA, LLC | $62.24 | 2025 | Ebglyss, Taltz |
| Dermavant Sciences, INC. | $60.71 | 2023 | Vtama |
| Sun Pharmaceutical Industries INC. | $47.68 | 2025 | |
| Organon LLC | $30.13 | 2025 | |
| Ucb, INC. | $27.14 | 2025 | Bimzelx |
| Glaxosmithkline, LLC. | $24.71 | 2023 | Nucala |
| Biofrontera INC. | $17.12 | 2025 | Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.